Chapter 2 Global DNA Read, Write, and Edit Market (BIO193B)
- Market Outlook
- Scope of Report
- Market Summary
- Market Dynamics and Growth Factors
- Emerging Technologies
- Segmental Analysis
- Regional Analysis
- Conclusion
- Current Market Overview
- Sequencing Technologies
- Sanger Sequencing
- Third-Generation Sequencing
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Emerging Technologies of Advances in Sequencing Technologies
- Advances in Sequencing Technologies
- Market Analysis by Technology
- Key Takeaways
- DNA Read (Sequencing)
- DNA Write (Synthesis)
- DNA Edit (Genome Editing)
- Market Analysis by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Sustainability to ESG Perspective
- ESG Practices in the DNA Read, Write, and Edit Industry
- Environmental Performance
- ESG Risk Ratings
- Conclusion
Chapter 3 The Chinese Market for DNA Sequencing (BIO152C)
- Market Outlook
- Scope of Report
- Market Summary
- Technological Advances
- Market Dynamics and Growth Factors
- Segmental Analysis
- Conclusion
- Market Overview
- Market Dynamics
- Market Driver
- Market Restraints
- Market Opportunities
- Emerging technologies and Developments
- Long-Read Sequencing Technologies
- Single-Molecule Real-Time (SMRT) Sequencing
- Artificial Intelligence (AI) and Machine Learning in DNA Sequencing
- Market Analysis by Product and Services
- Instruments and Consumables
- Services
- Chinese DNA Sequencing Market Analysis, by Technology
- Next-Generation Sequencing (NGS)
- Third-Generation Sequencing
- Sanger Sequencing
- Pyrosequencing
- Chinese DNA Sequencing Market Analysis, by Province
Chapter 4 Global DNA Forensics Market (BIO266A)
- Market Outlook
- Scope of Report
- Market Summary
- Technological Advances
- Market Dynamics and Growth Drivers
- Segmental Analysis
- Regional Analysis
- Conclusion
- Market Overview
- Market Dynamics
- Market Driver
- Market Restraint
- Market Opportunities
- Emerging Technologies Newest Technologies/Trends
- NGS
- NGI System
- Market Breakdown
- Key Takeaways
- Kits and Consumables
- Equipment
- Software
- Market Analysis by Source
- Key Takeaways
- Blood
- Bones
- Hair
- Others
- Market Analysis by Technique
- Key Takeaways
- PCR Amplification
- Short Tandem Repeat
- Capillary Electrophoresis
- NGS
- Others
- Market Analysis by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- Sustainability in the Global DNA Forensics Industry
- ESG Risks and Ratings: Understanding the Data
- Concluding Remarks on ESG
Chapter 5 Epigenetics: Technologies and Global Markets (PHM044D)
- Market Outlook
- Scope of Report
- Market Summary of Epigenetics: Technologies
- Market Overview of RNA Sequencing
- Epigenetics Overview
- DNA Methylation
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Trends
- Emerging Technologies and Developments
- Epigenome Editing
- Market Breakdown
- Market Overview
- Market Size and Forecast
- DNA Methylation
- Histone Modification
- RNA Modification
- Market by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Introduction to ESG
- Key ESG Issues in Epigenetics Pharmaceuticals andDiagnostics Market
- Sustainability Practices in Pharmaceuticals Manufacturing
- Sustainable Packaging
- Key ESG Issues in Epigenetics Research Tools Market
- ESG Risk Ratings Score - Understanding the Data
- Concluding Remarks
Chapter 6 mRNA: Therapeutics and Global Markets (BIO212C)
- Market Outlook
- Scope of Report
- Market Summary
- Market Growth Factors
- Emerging Technologies
- COVID mRNA Vaccines
- Regional Analysis
- Conclusion
- Market Overview
- Evolution of RNA Therapeutics
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Emerging Technologies and Developments
- Nanoparticles
- Modified mRNA
- Market Analysis
- Takeaways
- COVID mRNA Vaccines
- Non-COVID mRNA Vaccines and Therapeutics
- Market Breakdown Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Sustainability in the mRNA Therapeutics Industry
- ESG Risk Ratings
- ESG Performance Analysis
- Environmental Performance
- Social Performance
- Governance Performance
- Concluding Remarks
Chapter 7 Genome Editing: Technologies and Global Markets (BIO146D)
- Market Outlook
- Scope of Report
- Market Summary
- Market Overview
- Market Dynamics
- Market Driver
- Market Restrains
- Market Opportunities
- Market Challenges
- Emerging Technologies
- In Vivo Delivery of CRISPR
- Market Breakdown
- CRISPR-Cas
- TALEN
- Market by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Introduction to ESG
- Sustainability in Genome Editing: An ESG Perspective
- ESG Issues
- ESG Performance Analysis
- Environmental Performance
- Social Performance
- Governance Performance
- Concluding Remarks
Chapter 8 Genetic Modification Therapies Clinical Applications: Gene Therapies, Genetically Modified Cell Therapies, RNA Therapies, and Gene Editing (BIO159B)
- Market Outlook
- Scope of Report
- Market Summary
- Market Dynamics and Growth Factors
- Emerging Technologies
- Segmental Analysis
- Regional Analysis
- Conclusion
- Market Overview
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Emerging Technologies
- In Vivo Delivery of CRISPR
- Market Breakdown
- Key Takeaways
- RNA Therapy
- Gene-Modified Cell Therapy
- Gene Therapy
- Gene Editing
- Market Analysis by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Introduction to ESG
- ESG Risk Ratings
- Conclusion
Chapter 9 Cell-Based Assays: Technologies and Global Markets (BIO080F)
- Market Outlook
- Scope of Report
- Market Summary
- Market Overview
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Emerging Technologies and Developments
- AI and Machine Learning (ML) in Data Analysis
- Market Breakdown
- Cell-based Assays: Global Markets
- Consumables
- Instruments
- Software
- Services
- Market Analysis by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Sustainability in the Cell-based Assay Market
- Animal Testing
- Miniaturization and Automation
- Green Chemistry and Eco-friendly Materials
- 3D Cell Cultures and Tissue Models
- Waste Reduction and Optimization of Resources
- Improving Drug Discovery Efficiency
- ESG Risks and Ratings: Understanding the Data
- BCC Research Viewpoint
List of Tables
Table 1: Global Market for DNA Read, Write, and Edit, by Region, Through 2030
Table 2: DNA Read, Write, and Edit Technology Overview
Table 3: Global Market for DNA Read, Write, and Edit, by Technology, Through 2030
Table 4: Global Market for DNA Read, Write, and Edit, by Region, Through 2030
Table 5: Environmental Performance Initiatives in the DNA Read, Write, and Edit Market
Table 6: Social Performance Initiatives in the DNA Read, Write, and Edit Market
Table 7: Governance Performance Initiatives in the DNA Read, Write, and Edit Market
Table 8: ESG Risk Rankings for DNA Read, Write, and Edit Companies, 2025
Table 9: Chinese Market for DNA Sequencing, by Technology, Through 2030
Table 10: Chinese Market for DNA Sequencing, by Product and Service, Through 2030
Table 11: DNA Sequencing Instruments and Consumables Offered by Major Companies
Table 12: Chinese Market for DNA Sequencing, by Technology, Through 2030
Table 13: Chinese Market for DNA Sequencing, by Province, Through 2030
Table 14: Global Market for DNA Forensics, by Region, Through 2030
Table 15: Crime Rates, by Country, 2024
Table 16: Global Market for DNA Forensics, by Product Type, Through 2030
Table 17: Global Market for DNA Forensics, by Source, Through 2030
Table 18: Global Market for DNA Forensics, by Technique, Through 2030
Table 19: Global Market for DNA Forensics, by Region, Through 2029
Table 20: ESG Rankings for Major DNA Forensics Companies, 2025*
Table 21: Global Market for Epigenetics Research Tools and Reagents, IVDs andTherapeutics, by Product Type, Through 2029
Table 22: Key Programs/Consortiums to Support Epigenetic Research
Table 23: Companies Developing Products Based on Epigenome Editing Platforms
Table 24: Global Market for Epigenetics Research Tools and Reagents, by Study Method, Through 2029
Table 25: Global Market for Epigenetic Research Tools and Reagents, IVDs and Therapeutics, by Region, Through 2029
Table 26: Key Sustainability Practices in the Pharmaceuticals Industry
Table 27: ESG Risk Ratings of Key Companies in the Epigenetics Market, 2024
Table 28: Ethos Impact Inc. Score Card for Key Companies in the Epigenetics Market, 2024
Table 29: Global Market for mRNA Therapeutics, by Disease, Through 2030
Table 30: Global Market for mRNA Therapeutics, by Disease Type, Through 2030
Table 31: Global Market for mRNA Therapeutics, by Region, Through 2030
Table 32: Focus Areas in ESG Metrics
Table 33: ESG Rankings for Major mRNA Therapeutics Companies, 2025*
Table 34: ESG: Environmental Overview
Table 35: ESG: Social Factors Overview
Table 36: ESG: Governance Overview
Table 37: Global Market for Genome Editing, by Technology, Through 2030
Table 38: Global Market for Genome Editing, by Technology, Through 2030
Table 39: Global Market for Genome Editing, by Region, Through 2030
Table 40: Bioethical Issues and Risks Associated with CRISPR Technology
Table 41: ESG Rankings for Genome Editing Companies, 2025*
Table 42: ESG: Environmental Overview
Table 43: ESG: Social Overview
Table 44: ESG: Governance Overview
Table 45: Global Market for Genetic Modification Therapies, by Region, Through 2030
Table 46: Global Market for Genetic Modification Therapies, by Platform Technology, Through 2030
Table 47: Approved CAR T-Cell Therapies
Table 48: Global Market for Genetic Modification Therapies, by Region, Through 2030
Table 49: Key Focus Areas in ESG Metrics
Table 50: ESG Risk Rankings for Genetic Modification Therapies Companies, 2025
Table 51: Global Market for Cell-based Assays, by Region, Through 2029
Table 52: Global Market for Cell-based Assays, by Product Type, Through 2029
Table 53: Global Market for Cell-based Assays, by Region, Through 2029
Table 54: ESG Rankings for Major Cell-based Assay Companies, 2024*
List of Figures
Figure 1: Global Market Shares of DNA Read, Write, and Edit, by Region, 2024
Figure 2: Global Market Shares of DNA Read, Write, and Edit, by Technology, 2024
Figure 3: Global Market Shares of DNA Read, Write, and Edit, by Region, 2024
Figure 4: Key ESG Metrics of DNA Read, Write, and Edit Companies
Figure 5: Chinese Market Shares of DNA Sequencing, by Technology, 2024
Figure 6: Chinese Market Shares of DNA Sequencing, by Product and Service, 2024
Figure 7: Chinese Market Shares of DNA Sequencing, by Technology, 2024
Figure 8: Chinese Market Shares of DNA Sequencing, by Province, 2024
Figure 9: Global Market Shares of DNA Forensics, by Region, 2024
Figure 10: Global Market Shares of DNA Forensics, by Product Type, 2024
Figure 11: Global Market Shares of DNA Forensics, by Source, 2024
Figure 12: Global Market Shares of DNA Forensics, by Technique, 2024
Figure 13: Global Market Shares of DNA Forensics, by Region, 2024
Figure 14: Global Market Shares of Epigenetics Research Tools and Reagents, IVDs andTherapeutics, by Product Type, 2023
Figure 15: Global Market Shares of Epigenetics Research Tools and Reagents, by Study Method, 2023
Figure 16: Global Market Shares of Epigenetic Research Tools and Reagents, IVDs and Therapeutics, by Region, 2023
Figure 17: Selected Factors Driving ESG
Figure 18: Global Market Shares of mRNA Therapeutics, by Disease, 2024
Figure 19: Global Market Shares of mRNA Therapeutics, by Disease Type, 2024
Figure 20: Global Market Shares of mRNA Therapeutics, by Region, 2024
Figure 21: How a Strong ESG Proposition Can Benefit Businesses
Figure 22: Global Market Shares of Genome Editing, by Technology, 2024
Figure 23: Global Market Shares of Genome Editing, by Technology, 2024
Figure 24: Global Market Shares of Genome Editing, by Region, 2024
Figure 25: ESG Pillars
Figure 26: Advantages of ESG
Figure 27: Global Market Shares of Genetic Modification Therapies, by Region, 2024
Figure 28: Global Market Shares of Genetic Modification Therapies, by Platform Technology, 2024
Figure 29: Global Market Shares of Genetic Modification Therapies, by Region, 2024
Figure 30: Global Market Shares of Cell-based Assays, by Product Type, 2023
Figure 31: Global Market Shares of Cell-based Assays, by Region, 2023
